Details for Patent: 8,445,515
✉ Email this page to a colleague
Which drugs does patent 8,445,515 protect, and when does it expire?
Patent 8,445,515 protects TAVNEOS and is included in one NDA.
This patent has sixty-four patent family members in thirty-four countries.
Summary for Patent: 8,445,515
Title: | C5aR antagonists |
Abstract: | Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors. |
Inventor(s): | Fan; Pingchen (Fremont, CA), Greenman; Kevin Lloyd (Sunnyvale, CA), Leleti; Manmohan Reddy (Sunnyvale, CA), Li; Yandong (San Jose, CA), Powers; Jay (Pacifica, CA), Tanaka; Hiroko (Foster City, CA), Yang; Ju (Cupertino, CA), Zeng; Yibin (Foster City, CA) |
Assignee: | Chemocentryx, Inc. (Mountain View, CA) |
Application Number: | 12/643,229 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,445,515
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemocentryx | TAVNEOS | avacopan | CAPSULE;ORAL | 214487-001 | Oct 7, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,445,515
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2381778 | ⤷ Sign Up | 301166 | Netherlands | ⤷ Sign Up |
European Patent Office | 3508477 | ⤷ Sign Up | PA2022006 | Lithuania | ⤷ Sign Up |
European Patent Office | 2381778 | ⤷ Sign Up | 2022C/518 | Belgium | ⤷ Sign Up |
European Patent Office | 2381778 | ⤷ Sign Up | LUC00258 | Luxembourg | ⤷ Sign Up |
European Patent Office | 2381778 | ⤷ Sign Up | CA 2022 00022 | Denmark | ⤷ Sign Up |
European Patent Office | 2381778 | ⤷ Sign Up | 122022000029 | Germany | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |